SEC Filing Summary: FMG Acquisition Corp. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K, dated October 16, 2007, details the consummation of the Initial Public Offering (IPO) of FMG Acquisition Corp. on October 11, 2007. The registrant is a Delaware corporation operating as a special purpose acquisition company (SPAC).
Key Financial Metrics
- Gross Proceeds from IPO: $37,869,000 from the sale of 4,733,625 Units at $8.00 per Unit.
- Gross Proceeds from Private Placement: $1,250,000 from the sale of 1,250,000 warrants to FMG Investors LLC.
- Total Funds in Trust: $37,452,930 placed in a trust account for the benefit of public stockholders.
- Underwriters' Over-Allotment: The underwriters elected not to exercise the remaining balance of the over-allotment option (233,625 Units).
- Operating Metrics: The filing does not provide revenue, profit, cash flow, or margin data as the company has not yet commenced operations.
Material Changes
The primary material change is the transition from a private entity to a public company following the IPO. Consequently, the initial stockholders forfeited 110,344 shares of Common Stock due to the underwriters' decision not to exercise the full over-allotment option. Post-IPO, initial stockholders hold 1,183,406 shares, representing 20% of the issued and outstanding Common Stock.
Outlook, Risks, and Contingencies
The filing indicates that audited financial statements reflecting the proceeds have been issued (Exhibit 99.1). The private placement warrants contain specific restrictions: they are non-redeemable, may be exercised on a cashless basis by the sponsor, and cannot be transferred prior to 90 days following the consummation of a business transaction. The filing does not contain specific forward-looking guidance or risk factors beyond the standard structure of a SPAC.
Investor Verification Checklist
- Verify the terms of the Warrants included in the Units and the Private Placement.
- Confirm the $37,452,930 balance in the trust account via the audited financial statements (Exhibit 99.1).
- Review the press release (Exhibit 99.2) for additional details on the IPO execution.
- Monitor the status of the over-allotment option, which was explicitly declined by underwriters.